High dose of Atorvastatin versus Rosuvastatin as Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention
Last updated: 01 Jan 2025
10.21608/zumj.2019.15975.1426
CI-AKI, CA, S.Cr, PCI and AKI
mohamed
Sadawi
Fouad
Dep. of Cardiology, Ahmed Maher Teaching Hospital
mohamedfouad2303@icloud.com
0000-0001-7520-7477
Tarek
Abdelaziz
abdelmoneim
Dep. of Cardiology, Faculty of Medicine, Zagazig University
tarekaziz98@hotmail.com
nader
kandil
talat
cardiovascular ,faculty of medicine,zagazig university ,sharkia,cairo
nader.talat@yahoo.com
Alaa
Salama
Dep. of Cardiology,Faculty of medicine ,Zagazig University
salamaalaa137@gamil.com
27
3
24506
2021-05-01
2019-08-20
2021-05-01
469
476
1110-1431
2357-0717
https://zumj.journals.ekb.eg/article_46500.html
https://zumj.journals.ekb.eg/service?article_code=46500
209
Original Article
273
Journal
Zagazig University Medical Journal
https://zumj.journals.ekb.eg/
High dose of Atorvastatin versus Rosuvastatin as Preventive Strategies for Contrast-Induced Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention
Details
Type
Article
Created At
22 Jan 2023